Kim has extensive experience leading strategic engagements across the life sciences industry. In that context, she has helped pharma and biotech companies tackle a diverse range of strategic issues across the product lifecycle, with a specific interest in launch preparation and planning. Kim additionally has deep expertise across therapeutic areas, with a more recent emphasis within rare diseases, hematology/oncology, and cardiovascular/metabolic diseases. Kim is energized by forming collaborative partnerships with clients, helping them craft impactful and actionable solutions to their most pressing challenges.
Kim leverages 5+ years of experience in the life sciences, including translational clinical research at Massachusetts General Hospital prior to joining Clearview. She has spent the majority of her career specifically focused on growth strategy in the life sciences industry, supporting executives at the brand, therapeutic area, and corporate level. Kim earned her B.A. in History of Science from Harvard University.
Debbi Amanti Belanger